Medical Considerations in the Evaluation of Unrelated Hematopoietic Cell Donors*
Wednesday, January 9, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134740
Developed in cooperation with the National Marrow Donor Program
Director/Moderator: John Miller, MD, PhD
Speaker: John Miller, MD, PhD; Navneet Majhail, MD, MS
Intended Audience: Physicians, Technologists, Nurses, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Describe the medical assessment requirements for NMDP volunteer HC donors.
- Summarize how medical judgment is incorporated in the assessment of complex donor clearance cases.
- Describe common medical conditions that may require additional donor evaluation and how extended medical testing may affect the clearance timelines and/or outcomes.
Event Description: Unrelated allogeneic hematopoietic cell transplantation would not be possible without the altruistic donors of HC. The clinical and laboratory evaluation of donor medical suitability is designed to identify clinical issues that might put the donor at increased risk of donation of one or more sources of HCs (PBSC, bone marrow or therapeutic cells). This session will use a case study format to illustrate how the medical suitability of donors is evaluated to ensure their safety and to provide the safest and most effective HCs for patients undergoing HC transplantation.
*CT Program
Purchase the Presentation
Hemovigilance Report Generation and Analysis: How to Make the Most Out of Your Data
FREE SESSION
Wednesday, January 16, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134769
Director/Moderator: Barbee Whitaker, PhD
Speaker: Jackie Malasky, MPH
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching Level: Intermediate
Objectives:
- Review data analysis generation and analysis options within CDC's National Healthcare Safety Network (NHSN), Hemovigilance Module.
- Explain how to create data outputs using specific data ranges and variables.
- Explain how to create and save a frequently run report.
- Describe how to use data from the Hemovigilance Module as a learning tool in your facility.
Event Description: As more facilities join the NHSN's Hemovigilance Module, it is important to offer resources and tools that will allow facilities to take advantage of the opportunities for data collection and analysis. In this session, AABB's Patient and Donor Safety Center staff will present the basics of report generation, some of the higher level data output options, and analysis. Many of the topics that will be covered respond directly to questions hemovigilance users have asked, and new questions will be solicited prior to the presentation.
Purchase the Presentation
Current Approach to RBC Transfusion Thresholds: The FOCUS Trial and Beyond
Wednesday, January 23, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134741
Director/Moderator: Meghan Delaney, DO, MPH
Speaker: Jeffrey Carson
Intended Audience: Physicians, Technologists, Nurses, Perfusionists
Teaching Level: Intermediate
Objectives:
- Review why red cell transfusion thresholds are critical to guide patient transfusion decisions.
- Assess the FOCUS trial and how it will change transfusion practice.
- Describe how other studies of red cell transfusion thresholds were carried out and what their outcome means to medical practice.
Event Description: The session will describe what the red cell transfusion threshold should be in different patient populations. The lead investigator of the FOCUS trial, which studied red cell transfusion thresholds in patients with cardiac disease, will provide analysis of the study outcomes. Other important red cell transfusion threshold studies will be explored as well as the implications of these studies to the transfusion service.
Purchase the Presentation
Transfusion Transmitted Disease Update
Wednesday, January 30, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134742
Director/Moderator: Gail Moskowitz, MD
Speaker: Susan Stramer, PhD; Arthur Bracey, MD
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, Perfusionists
Teaching Level: Intermediate
Objectives:
- Review of current updates in Transfusion Transmitted Disease (TTD) testing.
- Discuss nucleic acid testing (NAT) for hepatitis B virus (HBV).
- Evaluate the effect of HBV NAT implementation on other HBV donor testing currently in use.
- Document the current status of testing for bacterial contamination of platelets.
Event Description: This audioconference will review the current status of testing for blood-borne pathogens with an emphasis on the utility of nucleic acid testing (NAT) for hepatitis B virus (HBV) and a discussion of the current status of testing for bacterial contamination of platelets. Donor testing for HBV by one or multiple analytes has been in place since the early 1970s; however, published residual risk estimates for this virus are considerably higher than those of HIV and HCV. Recent experience with HBV NAT has confirmed the value of both anti-HBc testing and HBV NAT in assuring blood safety, and allowed newer models to emerge demonstrating comparable residual risks for all three viruses. In addition, the implementation of HBV NAT has shown that testing for HBsAg may no longer be necessary. In the other portion of this program, a discussion of the current recommendations for bacterial testing of platelets will be presented. The utility of this information for both hospitals and blood centers will be reviewed.
Purchase the Presentation
Blood Center's Role in the Management of Recipient Adverse Events
Wednesday, February 6, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134743
Director/Moderator: Michele Hayes, MT(ASCP)SBB
Speaker: John Nobiletti, MD, PhD
Intended Audience: Physicians, Technologists, Nurses, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Discuss the pathophysiology, identification, management and prevention of various acute transfusion reactions.
- Determine the blood center's role in acute transfusion reaction investigations.
- Review the blood center's role in possible transfusion transmitted infectious disease investigations.
Event Description: Audience includes physicians, hospital blood bank technologists and nurses that want a general overview of the blood center's role in the investigation and management of recipient adverse events.
Purchase the Presentation
Assess Your Team to Ensure a Well-rounded Approach
Tuesday, February 12, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 1300
Director/Moderator: Mary O'Neill, MD
Speaker: Kathy Kaherl, MT(ASCP)SBB
Intended Audience: Physicians, Scientists, Nurses, Managers/Supervisors, CEOs/CFOs, Perfusionists
Teaching Level: Intermediate
Objectives:
- Recognize the characteristics of an effective team.
- Develop strategies for productive teamwork and determine what approach is inefficient.
- Manage teamwork in your organization to help achieve your corporate goals.
Event Description: Strong teamwork is the building block to any successful organization. This presentation will review the characteristics of an effective team and will help the audience develop strategies for ensuring a productive team as well as avoiding the pitfalls of the inefficient team. Your role in guiding the teams in your organization will help you achieve your corporate goals.
Purchase the Presentation
Obstetrical Hemorrhage and Hematological Care in Pregnancy
Wednesday, February 27, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134745
Director/Moderator: Meghan Delaney, DO, MPH
Speaker: Terry Gernsheimer, MD; Evelyn Lockhart, MD
Intended Audience: Physicians, Technologists, Nurses, Perfusionists
Teaching Level: Intermediate
Objectives:
- Assess the transfusion and hemostatic management of obstetrical hemorrhage.
- Discuss perinatal management of the patient with rare blood requirements.
- Describe the management of the thrombocytopenic patient.
- Describe the pathophysiology and pre and post natal management of NATP.
Event Description: This program will be a case based discussion about caring for obstetrical patients facing hemostatic challenge. Discussion will include transfusion planning for pregnancies complicated by sensitization to a high incidence antigen, which may require rare blood for delivery. Management of pregnant patients with platelet disorders will be highlighted as well as the interaction between maternal platelet antibodies and neonatal platelets (NATP).
Purchase the Presentation
Using Common Applications for Training and Change Tracking
Rescheduled to August 7
Understanding Cell Therapy Product In-Process Stability from Collection to Infusion*
Wednesday, March 20, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134747
Director/Moderator: Janice Davis, MAS, MT(ASCP) SBB
Speaker: Zbigniew Szczepiorkowski, MD, PhD, FCAP; David H. McKenna, MD; Donna Regan, MT(ASCP)SBB
Intended Audience: Physicians, Scientists, Technologists, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Discuss how CT product 'quality' is affected by time and temperature for periods between collection, processing, thawing and infusion.
- Review the effects of in-process storage conditions on the viability of nucleated cells.
- Describe approaches to evaluating and determining optimal parameters for short-term storage of novel CT products.
Event Description: The content of functional hematopoietic progenitor cells (HPCs) in a cell therapy product may be negatively affected by time lapses between product collection and infusion, or as a result of delays between processing and cryopreservation or between thawing and infusion. There are many different practices in current use that are designed to maintain viable HPCs, such as overnight refrigeration prior to processing and cryopreservation, cooling cells on ice prior to and during the addition of the cryoprotectant, and post-thaw washing. In addition to HPC products, novel cell therapy products may require development studies and validations to define acceptable in-process storage conditions. This session will focus on the effects of time and temperature on product quality for multiple cell therapy product types at various time points between collection and infusion.
*CT Program
Purchase the Presentation
MNS: Blood Group System Review and What You Need to Know in the Blood Bank
Wednesday, March 27, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134748
Director/Moderator: Kristina Williams, MT(ASCP)SBB, CQIA, CQA(ASQ)
Speaker: Monica Crosby, MLS(ASCP)SBB
Intended Audience: Scientists, Technologists, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Review the biochemistry and genetics of the MNS blood system.
- Describe antibodies to the MNS system antigens, including serologic characteristics.
- Provide an overview of the low and high prevalence antigens within the MNS system.
- List the antigens included in the MNS blood group system and include unique characteristics of the antigens in this system.
Event Description: This audio conference is designed to give an overview of the MNS system. Whether you work in a blood bank or a reference laboratory, this session will help you understand the different aspects of the MNS blood group system especially if you are seeking to obtain SBB(ASCP) certification. We will go through a wide range of information about the antigens and antibodies associated with the MNS system as well as some case studies and scenarios in regards to management of these antibodies in the blood bank. This program will emphasize what consideration may or may not need to be addressed when it comes to transfusion management.
Purchase the Presentation
Managing Different Generations in the Workplace NEW
Tuesday, April 16, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 1302
Director/Moderator: Colleen Aronson, MT(ASCP)SBB
Speaker: Judy Sullivan, MS, MT(ASCP)SBB
Objectives:
- Identify the generations in today's workplace.
- Describe how shared life experiences affect generational attitudes.
- Develop a plan for managing supervisors, co-workers and subordinates from the different generations.
Event Description: "That new med tech graduate has no work ethic!" "My supervisor is a technological dinosaur!" Does this sound like your workplace? At no time in history have individuals from so many generations been together in the workplace, and misunderstandings among the generations can cause tension, poor relationships and an unhappy work environment. This session examines the life events that have shaped the various generations and formed their beliefs and attitudes towards work. It also provides strategies for bridging the "generation gaps."
Purchase the Presentation
HTLA Antibodies: Identification and Management Strategies and Case Studies
Wednesday, April 17, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134749
Director/Moderator: Michele Hayes, MT(ASCP)SBB
Speaker: Molly Harrison
Intended Audience: Technologists, Managers/Supervisors
Teaching Level: Basic
Objectives:
- Describe the common characteristics seen with antibodies previously known as HTLA antibodies.
- Discuss the antibodies that demonstrate HTLA-like characteristics.
- Discuss the clinical significance of HTLA-like antibodies.
Event Description: This audioconference will focus on high titer low avidity(HTLA)-like antibodies. The "typical" serological characteristics of HTLA-like antibodies and the common antibodies that demonstrate HTLA-like activity will be discussed. Case studies will focus on the challenges faced when identifying HTLA-like antibodies and the different approaches to transfusion of patients with HTLA-like antibodies.
Purchase the Presentation
Protocols for Supporting HPC Transplant Patients Prior to, During, and After HPC Transplants*
Wednesday, April 24, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134750
Director/Moderator: Deborah Sesok-Pizzini, MD, MBA
Speaker: Thomas Klumpp, MD, FACP; Nicole Aqui, MD
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors
Teaching Level: Intermediate to Advanced
Objectives:
- Review special blood product requirements needed for compatible and safe blood transfusion to HPC transplant patients.
- Review criteria for selection of HPC donors with consideration of donor and recipient ABO/Rh(D) and selection of blood products for peritransplant transfusion support.
- Discuss transfusion complications following transplant including adverse hemolotyic reactions.
Event Description: Hematopoietic stem cell or progenitor cell transplants (HPC) are used as treatments for many hematological diseases and some non-hematological diseases including autoimmune disorders, solid tumors, and several inherited metabolic and immunodeficiency diseases. Due to the critical timing of transfusion support before, during and after HPC transplants, hospitals must develop safe and effective transfusion protocols to support these transplant patients. The purpose of this audioconference lecture is to review these protocols and special blood product requirements, criteria for selection of donor and recipients with emphasis on ABO/Rh(D) and red blood cell antigens, and immunological consequences following transplant including hemolytic reactions. The program will also be given to address any long-term transfusion needs following HPC transplants.
*CT Program
Purchase the Presentation
Lewis Blood Group System Review and What You Need to Know in the Blood Bank
Wednesday, May 1, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134751
Director/Moderator: Kristina Williams, MT(ASCP)SBB, CQIA, CQA(ASQ)
Speaker: Susanne Bishop, MLS(ASCP)CM SBBCM
Intended Audience: Scientists, Technologists, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Define the Lewis blood group system antigens.
- Determine Lewis red blood cell phenotypes based on the genetic interaction of Lewis and secretor genes.
- Discuss the prevalence, presentation, and clinical significance of Lewis blood group system antibodies.
- Recognize a clinically significant Lewis blood group system antibody.
Event Description: Whether you are a hospital blood bank technologist or an immunohematology reference laboratory technologist, especially if you are seeking to obtain SBB(ASCP) certification, this audioconference is for you. The focus of this program is to provide an in-depth review of the Lewis blood group system, including biochemistry, genetics, antigens, phenotypes, antibodies, and biological significance. This program will also offer direction for managing patients with Lewis blood group system antibodies and guidance pertaining to the Lewis blood group system for individuals preparing for the SBB certification exam.
Purchase the Presentation
Acceptance Testing for Reagents: When is it Required? How is it Done? New Date TBA
Wednesday, May 8, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134752
Director/Moderator: Michele Hayes, MT(ASCP)SBB
Intended Audience: Technologists, Managers/Supervisors
Teaching Level: Basic
Objectives:
- Discuss standards and regulations which relate to reagent acceptance testing.
- Determine which reagents require acceptance testing.
- Discuss testing methods that effectively determine the acceptability of a reagent for use.
Event Description: This basic level teleconference will focus on reagent acceptance testing. The regulatory requirements and standards will be reviewed. In addition, testing methods and acceptance criteria will be discussed.
Register Now
Use and Benefits of Electronic Medical Records: Best Practices and Educational Tools
Wednesday, May 15, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134753
Director/Moderator: Nancy Dunbar, MD
Speaker: Claudia Cohn, MD, PhD; Jim Perkins; Kevin Desrosiers
Intended Audience: Physicians, Technologists, Nurses
Teaching Level: Intermediate
Objectives:
- Identify ways to customize electronic order sets and transfusion reports to allow clinical staff easy access to patient lab results and transfusion history and provide links to educational information.
- Describe how a computer-generated algorithm can be designed to assist in regular audits of component use.
- Illustrate how computer generated best practice alerts can be used to provide decision support for physicians ordering transfusions and improve compliance with hospital transfusion guidelines.
Event Description: In this audioconference, three physicians will illustrate how they have leveraged the Epic electronic medical record platform to improve transfusion practice in their respective hospitals. The first speaker will describe how order sets were built to streamline and clarify the multiple orders needed for a transfusion event including the evaluation of transfusion reactions, how a summary report presents the laboratory data relevant to transfusion decision making, and how blood group antibodies can be reported across encounters as allergies. The second speaker will describe the creation of three databases which pull information from the electronic medical record and the laboratory information system and allows for semi-automated auditing and tracking of 100% of RBC transfusions, as well as platelet, plasma and cryoprecipitate use. The final speaker will demonstrate how use of best practice alerts provides real time decision support to assist ordering physicians in complying with evidence based hospital red cell transfusion guidelines.
Purchase the Presentation
Changes to the 6th edition of Standards for Cellular Therapy Services*
Wednesday, May 22, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134772
Director/Moderator: Magali J. Fontaine, MD, PhD
Speaker: Julie Allickson, PhD, MS, MT(ASCP); Magali J. Fontaine, MD, PhD; Richard Haspel, MD, PhD
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, CEOs/CFOs
Teaching level: Intermediate
Objectives:
- Explain the rationale for revised requirements.
- Determine ways to implement the new and revised requirements.
- Identify existing policies, processes and procedures that may need to be changed in order to conform to the 6th edition.
Event Description:The speakers in this program will summarize the new and revised requirements incorporated into the 6th edition of Standards for Cellular Therapy Services. In addition, the rationale for the changes will be reviewed.
*CT Program
Register Now
Deciphering Imputability for Hemovigilance Reporting NEW
FREE SESSION
Wednesday, June 5, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134773
Director/Moderator: Barbee Whitaker, PhD
Speaker: Michele Herman
Objectives
- Define "imputability."
- Discuss the importance of including imputability in adverse reaction reports.
- Explain the difference between case definition, severity, and imputability within the context of the National Healthcare Safety Network (NHSN).
- Explain the options for imputability: Definite, Probable, Possible, Not Determined, Doubtful, and Ruled Out.
- Provide case studies illustrative of ways to code imputability.
Event Description: The NHSN's Hemovigilance Module primarily collects information on transfusion adverse reactions. Along with a diagnosis of the adverse reaction, the surveillance system, used by more than 150 hospitals to date, requires the user to code for the case definition, severity, and imputability. Imputability, or the strength of the relationship of the transfusion to the reaction, is critical to understanding adverse events. This audioconference will provide an in-depth look at how to use patient records to assign imputability according to the NHSN surveillance protocol. The intended audience for this audioconference is those interested in hemovigilance and adverse transfusion reactions as well as people who are participating in the NHSN.
Register Now
Succession Planning While Getting Ready for the Next Level
Tuesday, June 11, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 1302
Director/Moderator: Mary O'Neill, MD
Speaker: Guanah Davis, MT (ASCP) MBA
Intended Audience: Managers/Supervisors, CEOs/CFOs
Teaching Level: Intermediate to Advanced
Objectives:
- Describe the value of succession planning in this economic climate.
- Determine how to identify and develop those within your organization suited for greater responsibilities.
- Examine the methods of grooming high-potential employees for advancement.
Event Description: Succession planning allows organizations to lead from within. It is a way to identify and nurture the future leadership of your organization. This presentation will describe the importance and value recognized by an organization with a good succession plan and help the audience understand the key components.
Register Now
Hemolytic Transfusion Reaction Investigations- Serology, Paperwork and Patients
Wednesday, June 12, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134754
Director/Moderator: Jayanna Slayten, MS, MT(ASCP)SBB
Speaker: Suzanne Davisson, BS, SBB(ASCP)CM; Jeremy Bigge, DO
Intended Audience: Physicians, Technologists
Teaching Level: Intermediate to Advanced
Objectives:
- Provide an overview of recognition and response to a suspected hemolytic transfusion reaction.
- Review the serologic investigation of suspected hemolytic transfusion reaction.
- Explore "how far we go" with the serologic testing to determine the cause of the reaction in the patient.
- Review the signs/symptoms and clinical management of a patient undergoing transfusion reaction.
- Discuss the reporting of a hemolytic transfusion reaction and how this ties into hemovigilance.
Event Description: The risk of hemolytic transfusion reaction (HTR) as a non-infectious complication of blood transfusion is a risk which is addressed daily in transfusion services. The risk of HTR is mitigated daily with quality serologic testing, clerical accuracy and good patient management. This conference reviews the serologic and clinical picture of hemolytic transfusion reactions. HTR will be presented from the aspect of the serology focusing on what testing is critical for the proper investigation of a HTR. To partner with the serology, HTR will be reviewed from the clinician's perspective. The serology and clinical picture are summarized in the documentation of the HTR. This presentation will also review the reporting structure for HTR in U.S. transfusion services.
Register Now
Incompatible Platelets NEW
Wednesday, July 17, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134759
Director: Gail Moskowitz, MD
Moderator: Benjamin Greco, MD
Speaker: Nancy M. Dunbar, MD
Objectives:
- Differentiate ABO identical, minor and major incompatible platelet transfusion.
- Recognize clinical and theoretical risks associated with ABO incompatible platelet transfusion.
- Evaluate risks and benefits associated with transfusion practices allowing for platelet ABO incompatibility.
Event Description: The importance of ABO blood group system compatibility in platelet transfusion is a subject of ongoing debate. Although there are theoretical advantages to pursuing a strict policy of providing exclusively ABO-compatible products, resource challenges may make this impractical for many transfusion services. Moreover, data supporting a net clinical benefit for this practice have been lacking. This presentation reviews ABO compatibility in the setting of platelet transfusion and examines the risks and benefits associated with transfusion practices allowing for platelet ABO incompatibility. Clinical cases illustrating complications associated with incompatible platelet transfusion will be presented.
Register Now
Most Common Citations from AABB/CAP
Wednesday, July 24, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134757
Director/Moderator: Colleen Aronson, MT(ASCP)SBB
Speaker: Holly Rapp, MT(ASCP)SBB, CQA(ASQ)CMQ/OE; Denise Driscoll, MS, MT(ASCP)SBB
Intended Audience: Technologists, Managers/Supervisors
Teaching Level: Basic to Intermediate
Objectives:
- Review the most common AABB and CAP assessment citations.
- Determine if these situations affect your location.
- Assess how to remedy the citations.
Event Description: Hear from the experts what are the most common citations for AABB and CAP inspections so that you can evaluate your facility and see if these may also be affecting your facility. Learn ways to correct the violations.
Register Now
Factors that Regulate Red Cell Alloimmunization: Lessons from Animal Models
Wednesday, July 31, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134758
Director/Moderator: Meghan Delaney, DO, MPH
Speaker: James Zimring, MD, PhD; Jeanne Hendrickson, MD
Intended Audience: Physicians, Scientists, Technologists
Teaching Level: Intermediate to Advanced
Objectives:
- Describe the function of the immune system in relation to red cell alloimmunization.
- Review factors in patient biology that regulate red cell alloimmunization.
- Discuss factors relating to blood donor biology that may affect patient sensitization to red cells, as well as transfusion outcomes.
Event Description: Scientific understanding of red cell alloimmunization is bolstered by using mouse models to study the interaction of the immune system with transfused red cells. In this program, two leading researchers will provide the most up to date information about immunity and alloimmunization considering both patient and blood donor factors. How this information will inform the practice of human transfusion will also be discussed.
Register Now
Project Management 101 for Transfusion Medicine: Tools and Practices
Tuesday, August 6, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 1303
Director/Moderator: Colleen Aronson, MT(ASCP)SBB
Speaker: Michael Breard, MS, MT(ASCP)SBB, CQA(ASQ), PMP(PMI); Melanie Descoteaux, PMP, MT(ASCP)
Objectives:
- Review the basics of Project Management and the PM methodology.
- Introduce Project Management Tools such as PMBOK, Enterprise Systems, and manual project management techniques.
- List the benefits of project management implementation to the organization.
Event Description: This program will address project management methods and techniques to the transfusion medicine practitioner. Project management professionals will present information on project management tools and successess in real life settings. The attendees will understand how standardized project management methodologies can assist with time management, costs and scope resulting in decreased risk and increased quality solutions to organization and stake holders.
Register Now
Using Common Applications for Training and Change Tracking
Wednesday, August 7, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134746
Director/Moderator: Colleen Aronson, MT(ASCP)SBB
Speaker: Bonnie Averkamp; Yolanda Moore
Intended Audience: Technologists, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Discuss advantages to using common applications.
- Review the features of Excel which can be used to standardize, validate and secure data input.
- Utilize MS Outlook's Tasks and Calendar features to stay organized and efficient.
Event Description: This audioconference will discuss several methods for using common computer applications to track, simplify and standardize routine tasks. The use of various features in Microsoft Excel to process statistics, validate input data and manipulate entries will be discussed. A few pointers will be given to help you use MS Outlook Tasks and Calendar efficiently.
Register Now
Toolbox of Quality Improvement: What Can EVERYONE do to Improve Quality
Wednesday, August 21, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134761
Director/Moderator: Jayanna Slayten, MS, MT(ASCP)SBB
Speaker: Barbara R. Swanson, M.Ed., MT(ASCP), CQA(ASQ); M. Sue Zaleski, MA SCT(ASCP)HT
Intended Audience: Physicians, Technologists, Nurses, Perfusionists, CEOs/CFOs, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Review the building blocks of quality control, quality assurance and quality management systems.
- Provide a review of the quality system essentials and discuss how the QSEs are eveyone's responsibility.
- Encourage and explain all staff members' responsibility for quality.
- Explain what makes up the Toolbox of Quality Improvement.
Event Description: Quality is the core of the Blood Bank. With so many aspects of quality running through all facets of the blood bank, it's everyone's responsibility to make QUALITY #1. This session will provide the encouragement and tools of how each person in a blood bank can make quality a priority. A toolbox makes every job easier. A Quality Toolbox can make any blood bank task easier and more efficient!
Register Now
Duffy Blood Group
Wednesday, September 11 , 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134762
Director/Moderator: Meghan Delaney, DO, MPH
Speaker: Geralyn Meny, MD; Margaret Keller, MD
Objectives:
- Review the serologic and clinical characteristics of the Duffy blood group antibodies.
- Assess the clinical significance of the Duffy glycoprotein, including its role as a malaria and as a chemokine receptor.
- Describe genotyping methods used to predict Duffy antigen status.
- Determine how molecular testing for Duffy can help in transfusion medicine.
Event Description: This audioconference will provide an overview of the Duffy blood group system. The antigens of the Duffy blood group system are located on a glycoprotein known as Duffy antigen receptor for chemokines (DARC) which is expressed in both erythroid and non-erythroid tissues. The structure and functional role of the DARC receptor that contains the Duffy blood group antigens will be discussed, including the structure of the gene that encodes DARC. Antibodies to Duffy antigens, which are usually clinically significant, will be reviewed. The conference will conclude with a case report demonstrating the benefit of molecular genotyping for Duffy in transfusion medicine.
Register Now
Update on Umbilical Cord Blood Banking and Transplantation*
Wednesday, September 18, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134755
Developed in cooperation with the American Society for Blood and Marrow Transplantation
Director/Moderator: Karen Ballen, MD
Speaker: Rebecca Haley, MD, MT(ASCP)SBB; Andromachi Scaradavou
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching Level: Intermediate
Objectives:
- Review the basics of cord blood banking.
- Describe cord blood donor ecruitment issues.
- Discuss the selection of best cord blood unit.
Event Description: The speakers will address current issues in cord blood banking by case studies and review of the literature. The topics will include donor recruitment, basics of cord blood banking, and selection of the optimal cord blood unit.
*CT Program
Register Now
Quality is Not Just Compliance...Knowing the Difference
Tuesday, October 1, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 1304
Director/Moderator: Mary O'Neill, MD
Speaker: Paul Sullivan, MBA
Intended Audience: Managers/Supervisors, CEOs/CFOs
Teaching Level: Intermediate
Objectives:
- Explain to your team the customer values and how their work impact customer satisfaction.
- Create a culture that embraces new changes, pilots, test cases or anything that can make things better.
- Develop metrics and tracking that enables stars to shine and those that need improvement... to improve.
Event Description: Quality is driven by an overall focus on performance and accountability. Compliance is just one outcome of a high quality team. This session will summarize a series of management efforts in the blood banking context that highlight one blood bank's efforts to create a high quality culture.
Register Now
Intravenous Immunoglobulin Therapy and Impact on Testing NEW
Wednesday, October 2, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134765
Director/Moderator: Michele C. Anastasi, MS, MT(ASCP)SBB
Speaker: Gregory A. Denomme, PhD; Matthew Karafin, M.D.
Intended Audience: Physicians, Technologists, Managers/Supervisors
Teaching Level: Intermediate to Advanced
Objectives:
- Review the manufacture of IVIG and immunoglobulin content.
- Review the labeled uses of IVIG and the recommended therapeutic doses.
- Determine the impact IVIG therapy has on recipient infectious disease testing.
- Identify the signs of immune hemolysis related to IVIG therapy.
- Summarize the laboratory testing required to confirm immune-mediated hemolysis.
Event Description: Intravenous immunoglobulin (IVIG) is used to treat both primary and secondary immune deficiencies along with a variety of autoimmune and inflammatory disorders. IVIG products are safe and effective for their labeled use. IVIG contains IgG against blood group A and B antigens and adverse transfusion reactions have been reported. In addition, IVIG therapy can result in false positive tests for infectious markers, which can complicate patient testing. This audioconference will review the use of IVIG in the management of immune disorders, the adverse immune reactions, and its effect on patient testing.
Register Now
HCT Product Quality and Viability Assessment for the CT Laboratory*
Wednesday, October 23, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134763
Director/Moderator: M. Vic Lemas, PhD
Speaker: Michael Creer, MD, PhD
Intended Audience: Physicians, Scientists, Technologists
Teaching Level: Intermediate
Objectives:
- Discuss the use of trypan blue, acridine orange/propidium iodide (AO/PI) and other similar techniques to assess total nucleated cell (TNC) viability based on "dye exclusion" by viable cells.
- Discuss the original ISHAGE method for CD34+ cell quantitation and recent modifications of the original method to include the use of fluorescent beads for single-platform cell counting and inclusion of 7-AAD to assess CD34+ cell viability.
- Describe approaches that permit the use of flow cytometry to specifically evaluate the viability of the granulocyte, monocyte and lymphocyte populations separately using 7-AAD during the same analysis of CD34+ cell viability and effects of time and temperature on dye-based cell viability assessment.
- Discuss the results of external proficiency testing programs to evaluate the performance of different laboratories in the determination of cell viability and discuss the challenges to the standardization of cell viability assessment and measurement of "viable" CD34+ cell count.
- Discuss factors influencing the results obtained by these methods and how results differ when measured before cryopreservation and after thaw.
Event Description: Engraftment following transplantation of an HCT product is critically dependent upon infusion of a sufficient number (dose) of viable, functional hematopoietic stem/progenitor cells (HPC). Accordingly, although the total nucleated cell (TNC) and CD34+ cell content are the primary features that are used to determine whether an HCT product is suitable for transplantation, it is also vitally important to evaluate HPC viability and function. This is especially true when HCT processing is delayed, the HCT product is manipulated, the HCT product requires shipment over large geographic distances and/or the HCT product is cryopreserved. This session will provide a focused discussion of commonly used methods to assess TNC and HPC cell viability with specific emphasis placed on improving the general understanding of how different methods work, the advantages and limitations of different approaches, the practical details of implementing these methods in the cell therapy laboratory and the unique challenges encountered with attempts to standardize these techniques.
*CT Program
Register Now
Building a New Blood Bank: Designing, Planning and Pulling It All Together
Wednesday, October 30, 2013
2:00 – 3:30 PM (ET) 6:00 – 7:30 (GMT)
Program # 134766
Director/Moderator: Nancy Dunbar, MD
Speaker: Neal Underland, BA; Christine Freeman
Intended Audience: Technologists, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- Describe ways to incorporate LEAN design principles in planning a new blood bank space.
- Identify planning considerations including the purchase and qualification of new equipment, customer communications and project timelines.
- Recognize ways to optimize the transition and common pitfalls to avoid.
Event Description: In this audioconference, two speakers will share their recent experiences with getting blood banks up and running in new locations. The process includes designing the new locations, optimizing the layout within the constraints of the physical space, planning for new equipment needs and setting timelines to meet the target begin date. The final phase involves coordinating the last minute details to successfully get to opening day. Speakers will share challenges they encountered during the process, what they learned and why it was all worth it.
Register Now
Mobilization with Plerixafor (Mozobil) — Why, When and How *
Wednesday, November 6, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134767
Director/Moderator: Joseph Schwartz, MD
Speakers: Abba Zubair, MD, PhD; Michele Cottler-Fox
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching Level: Basic to Intermediate
Objectives:
- Understand principles of mobilization with Plerixafor (Mozobil).
- Understand cost effective aspects associated with Plerixafor (Mozobil) mobilization
- Understand predictabilty models for mobilization with/without Plerixafor (Mozobil).
- Mobilization using Plerixafor (Mozobil)-current evidence.
Event Description: This audio conference will describe the mechanism of action of Plerixafor (Mozobil) and will look at its current use. Algorthims for the incorporation of Plerixafor (Mozobil) in the mobilization of peripheral blood HPCs will be shared with the audience. A predictive formula to target the need for Plerixafor (Mozobil) and its use in the most cost —effective way will be presented.
*CT Program
Register Now
Using Strength Deployment Inventory in Leadership Development
Wednesday, November 13, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134768
Director/Moderator: Colleen Aronson, MT(ASCP)SBB
Speaker: Angela Bingham; Lisa Kustka, MT(ASCP)BB
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, CEOs/CFOs, Perfusionists
Teaching Level: Basic to Intermediate
Objectives:
- Provide an introduction to the Strength Deployment Inventory (SDI), the learning model for the effectively and accurately understanding the motive behind behavior.
- Determine ways that one's personal strengths may be used to improve relationships with others
- Review how motivational values affect behavior.
Event Description: The SDI is a Self-Awareness tool to improve relationship and manage conflict more effectively. The SDI looks at motivation when things are going well and during conflict. This tool is a practical way to make business and relationships more productive. Also it is an easy way to recognize and manage conflict while turning it into a positive force for change. The SDI is also a memorable way to discover your own relating style and potential sources of conflict for yourself and others, and a proven way to look beyond other people's "behavior" to recognize and understand the motivation behind it. This program will explain how to effectively use this tool in leadership development.
Register Now
Role of the Transfusion Service Safety Officer: What Can a TSO Do for You?
Wednesday, December 4, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 134771
Director/Moderator: Jayanna Slayten, MS, MT(ASCP)SBB
Speaker: Nanci Fredrich, RN, BSN, MM; Catherine A. Shipp, RN, BSN, HP(ASCP)
Intended Audience: Physicians, Technologists, Nurses, Perfusionists, CEOs/CFOs, Managers/Supervisors
Teaching Level: Intermediate
Objectives:
- To appreciate the role of the Transfusion Safety Officer within the Hospital community.
- To discuss the primary responsibilities of the TSO.
- To evaluate the appropriate person to serve as the TSO.
- To provide scenarios where the TSO made critical contribution to continued improvement in patient blood management
Event Description: The role of the Transfusion Safety Officer continues to be developed in US Transfusion Services. The TSO is a critical player in the continued tracking, trending and continued improvement in the utilization of blood products. The TSO role has developed and implemented in many ways. This program seeks to explain the role of the TSO, the advantages of the TSO in any size Transfusion Service and discuss how the TSO is the key to continue improvement of total patient blood management.
Register Now
Feedback and Recognition in the Workplace: Think Outside the Annual Performance Review
Tuesday, December 10, 2013
2:00 – 3:30 PM (ET) 7:00 – 8:30 (GMT)
Program # 1305
Director/Moderator: Dina Hannah, MBA/HCM, BS, MT(ASCP)H, SBB, CIPP
Speaker: Roy Prasad
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, CEOs/CFOs, Perfusionists
Teaching Level: Basic
Objectives:
- Determine where you as a manager are on the recognition spectrum.
- Provide vital tools to management on how they can become more effective in recognizing employees.
- Review some practical recognition programs, events, and tips managers can implement immediately to make a difference in their workplaces.
Event Description: In today's workplace, employee recognition is no longer an option. Managers who can master the skill of truly recognizing their employees will have happier, more productive people- and we all know what that means for a business. This presentation will focus on instilling managers with the right mindset to support and recognize employees. Service awards and bonuses are all fine and dandy, but if managers really want to make a difference in their workplaces, they've got to look in the mirror first. Join us for an in depth presentation on self-reflection, self-analysis and ultimately, self-metamorphosis.
Register Now
Continuing Education Credit
Access your continuing education credit certificates online!
All audioconference participants will be granted access to their CE credits and attendance verifications online after completing a short evaluation. All credits will be personalized, tracked and maintained online so that participants can access their records at any time. Simply fill in the attendance sheet with the necessary information (including an email address for each participant) and visit the Live Learning Center at www.aabb.org/livelearningcenter at least 48 hours after the audioconference. Only those participants who signed the attendance sheet will be granted the appropriate continuing education credits.
Continuing Medical Education Credit
AABB is accredited by the Accreditation Council on Continuing Medical Education, provider number 0000381, to provide continuing medical education for physicians. AABB designates each audioconference for a maximum of 1.5 contact hours in Category 1 credit toward the American Medical Association Physicians' Recognition Award. Each physician should claim only those credit hours spent in the activity.
California Nurses
AABB is approved by the California Board of Registered Nursing, provider number 4341, as a provider of continuing nursing education activities. AABB designates each audioconference for a maximum of 1.8 contact hours. California nurses must provide a personal signature and other required information on the attendance form.
California Clinical Laboratory Personnel
AABB is an approved accrediting agency for continuing education for California-licensed clinical laboratory personnel. Each audioconference has been approved for a maximum of 1.5 contact hours. AABB's accrediting agency number is 0011. California clinical laboratory personnel must provide a personal signature and other required information on the attendance form. Credit earned through attendance at audioconferences may be used to fulfill the state requirement for continuing education hours to maintain licensure status.
Florida Clinical Laboratory Personnel
AABB is approved by the Florida Board of Clinical Laboratory Personnel, Provider Number 50-4261-1, as a provider of continuing education programs for Florida-licensed clinical laboratory personnel. Each audioconference has been approved for a maximum of 1.8 contact hours. Florida clinical laboratory personnel must provide a personal signature and other required information on the attendance form.
Ireland
The Professional Enhancement Program (PEP) of the Irish Academy of Medical Laboratory Sciences will offer credit for AABB audioconferences. PEP registrants who participate within the Blood Transfusion Service Board will receive PEP certificates of attendance at no additional charge.
United Kingdom
The Institute of Biomedical Science (IBMS) in the United Kingdom accredits AABB for Continuing Professional Development. Those who have registered on the IBMS Scheme will earn 0.2 educational category credit towards the annual 4.0 credit requirement. Participants are asked to use reference # TS011N98. Questions regarding continuing education credits should be directed to the AABB Professional Development Department at +1.301.215.6482 or professionaldevelopment@aabb.org.